- Generative's AI Newsletter
- Posts
- 🤖 Musk Merges xAI & X, Apple’s AI Health Push, OpenAI’s Boardroom Scandal
🤖 Musk Merges xAI & X, Apple’s AI Health Push, OpenAI’s Boardroom Scandal
Is Musk’s AI power play about to change everything?

Welcome, AI Watchers!
Elon Musk is officially merging xAI and X, turning the platform into an AI powerhouse. Meanwhile, Apple is developing an AI-driven health coach, OpenAI’s internal drama is back in the spotlight, and Oxford scientists are accelerating Alzheimer’s drug discovery with AI.
In today’s Generative AI Newsletter:
Musk merges xAI & X: X will now serve as a training ground for xAI models, giving Musk a competitive edge in AI.
OpenAI’s boardroom drama resurfaces: A new book reveals details about Sam Altman’s firing and the internal chaos at OpenAI.
Apple’s AI health coach: Apple is training an AI with doctor insights for personalized health advice.
AI in Alzheimer’s research: Oxford scientists are using AI knowledge graphs to speed up drug discovery.
🤖 Musk Merges xAI & X, Blurring AI & Social Media

Image Credit: X
Elon Musk’s AI company xAI has acquired X (formerly Twitter) in an all-stock deal, consolidating his AI and social media ventures. The move values xAI at $80B and X at $33B, with both now under xAI Holdings Corp.
How This Reshapes AI & Social Media:
X Becomes an AI Powerhouse: With 600M+ active users, X now acts as a real-time data pipeline for AI model training and deployment.
xAI Gains Unmatched Training Data: X’s vast archive of posts gives xAI a significant edge over OpenAI, Google, and Anthropic in AI development.
Musk’s AI vs. OpenAI: Musk is doubling down on his rivalry with OpenAI, even making a $97B takeover bid for the company.
X’s Financial Lifeline?: X’s stagnant revenue and $12B debt have weighed it down. This AI pivot could be Musk’s way of securing new investor confidence.
Social Media: This deal shifts X from a traditional social network to an AI-driven data source, mirroring moves by Meta and Google.
With xAI now fully integrated into X, Musk is betting that the future of social media isn’t in ads or engagement—it’s in AI dominance. As xAI scales, its next challenge will be proving it can compete with OpenAI and Google on a global scale.
📖 OpenAI’s Boardroom Drama Resurfaces in New Book

Image Credits: Elizabeth Frantz/Reuters
An excerpt from "The Optimist: Sam Altman, OpenAI, and the Race to Invent the Future" by Keach Hagey has revealed new details about Sam Altman’s shocking 2023 firing and reinstatement. The book sheds light on the internal conflicts, AI safety concerns, and power struggles that nearly broke OpenAI apart.
What the Book Reveals:
Altman’s Alleged Misconduct: Then-CTO Mira Murati and co-founder Ilya Sutskever compiled evidence of Altman’s toxic behavior and dishonesty, including misleading the company’s legal team about GPT-4 Turbo’s safety review.
Secret Ownership of OpenAI’s Fund: The board discovered that Altman personally owned the OpenAI Startup Fund, contradicting his public claims that it was company-managed.
Internal Power Struggles: Sutskever presented the evidence to the board, leading to Altman’s ousting and Murati’s appointment as interim CEO.
Peter Thiel’s Warning: Just weeks before the chaos, Thiel allegedly warned Altman of rising tensions with AI safety advocates within OpenAI.
The Reinstatement Aftermath: The move backfired when OpenAI employees threatened mass resignations, forcing Altman’s return and leading to the departure of Murati and Sutskever.
With the full book set to release in May, these revelations may revive debates on OpenAI’s governance and leadership. With Altman back at the helm and OpenAI pushing forward, the question remains—will these revelations change anything?
🍏 Apple’s AI Health Coach in the Works

Image Credit: Bloomberg
Apple is developing a new AI-driven health agent as part of Project Mulberry, aiming to offer personalized health advice directly through its Health app. The move marks Apple’s most significant push into AI-powered healthcare yet.
Key Developments:
AI-Powered Health Coaching: Building on Project Quartz, the AI agent will help users track exercise, sleep, and nutrition while providing personalized recommendations.
Doctor-Trained AI: Apple is training its AI on in-house medical experts’ data and recruiting external doctors to create video explainers on health conditions.
Food Tracking Focus: A new nutrition-tracking feature will put Apple in direct competition with MyFitnessPal and Noom.
Potential Release Soon: The AI health agent could launch as early as iOS 19.4, expected in spring or summer 2025.
Challenges in AI Healthcare: Apple has faced past setbacks, such as removing its blood oxygen sensor from Apple Watch after a legal dispute with Masimo.
As Apple bets big on AI in healthcare, it joins a broader industry trend: 9 in 10 healthcare executives expect positive ROI from AI investments, fueling even more adoption. Will Apple’s AI health coach redefine digital wellness—or face the same roadblocks as before?
🧠 AI-Powered Databases Accelerate Alzheimer’s Drug Discovery

Image Source: Getty Images
Researchers at the Oxford Drug Discovery Institute are leveraging AI and knowledge graphs to speed up drug discovery for Alzheimer’s disease, helping scientists sift through massive biomedical datasets nearly 10 times faster.
Key Developments:
AI-Powered Data Analysis: Scientists can now prioritize genes and proteins faster by using AI to analyze studies and journals.
Knowledge Graphs for Faster Insights: The team built a large-scale knowledge graph with Graphwise, cutting gene evaluation time from weeks to days.
Identifying Drug Targets: Researchers analyzed 54 genes linked to the immune system, narrowing down potential Alzheimer’s drug targets.
Connecting AI to Biomedical Research: AI models are being integrated with vector databases to improve data organization and research accuracy.
Biomarker Validation in Progress: The next step is experimental validation to confirm if the identified targets impact brain cell behavior.
With AI-driven research tools, scientists can navigate vast biomedical datasets more efficiently, making breakthroughs in Alzheimer’s treatment faster and more precise. Will AI reshape the future of neurological drug discovery?

🚀 Boost your business with us—advertise where 10M+ AI leaders engage
🌟 Sign up for the first AI Hub in the world.
Reply